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Optical coherence tomography, physiologic vascular function, safety and efﬁcacy
preclinical studies of porcine peripheral vessels dilated with drug-coated balloon
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Background: This study conducted imaging, pharmacokinetic, safety and efﬁcacy
studies to characterize the paclitaxel (PTX) coating of the Freeway (Eurocor,
Germany) peripheral vessel drug-coated balloon (DCB).
Methods: Fifty-seven domestic swine underwent percutaneous Freeway overstretch
balloon dilation for 1 and 2 minutes of both femoral and iliac (4-5 and 6-8 mm
diameter, respectively) arteries, controlled by angiography and optical coherence
tomography (OCT). Tissue PTX concentrations and the vascular function were
measured at 1h, 1, 3 and 9 days. Neointimal growth was quantiﬁed by OCT and
computerized planimetry by a blinded observer 5 weeks post-DCB use in a random-
ized (DCB vs. non-coated control balloon) pre-clinical study.
Results: The peripheral artery tissue PTX levels were 141.937.9 vs. 566.3179.9,
43.213.6 vs. 149.471.8, 23.48.4 vs. 30.016.6 and 3.22.4 vs. 4.01.1 ng/mg
using 1 vs. 2 min balloon inﬂation time at 1h, 1, 3 and 9 days post-DCB use, respectively.
OCT revealed severe vessel injury after gross overdilation of peripheral vessels including
dissection and thrombus formation without acute vessel closure. Five-week histopa-
thology showed similar ﬁbrin and inﬂammation score in DCB/plain balloon groups.
Similar to the ﬁndings of histomorphometry, quantitative OCT resulted in signiﬁcantly
(p<0.05) lower %diameter (and%area) stenosis in Freeway as compared to plain balloon
group (16.34.8 vs 22.56.4% in femoral and 19.74.0 vs 28.36.5% in iliac arteries).
OCT proved to be more sensitive as compared to angiography in assessment of vascular
stenosis and showed shrinkage (constrictive remodeling) of the vessels at the most severe
stenosis site. DCB led to increased vasoconstrictor tone and impairment of endothelium-
dependent vasodilation in a tissue PTX dose-dependent manner.
Conclusions: In a pre-clinical porcine model, PTX tissue concentration from the
Freeway DCB is related to time of balloon inﬂation. DCB reduced the neointimal
hyperplasia in peripheral arteries compared to uncoated balloons. Vascular function
impairment was directly associated to higher tissue PTX concentration, which might
limit the technical effort to deliver higher amount of drug into the arteries.
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Background: The index of microcirculation resistance (IMR) allows the invasive
evaluation of the coronary microcirculation status given way to new research possi-
bilities. Our purpose is to compare two doses of intracoronary papaverine, 5 and 10
mg, for the induction of maximal hyperemia and IMR evaluation and to assess their
evolution in time.
Methods: Measurements of IMR were performed in 8 pigs. A pressure wire, 0.014
PressureWireTM Certus (St. Jude Medical), was positioned in left anterior descending
artery. IMR was measured in resting and in maximal hyperemia induced with intra-
coronary papaverine, 5 and 10 mg, and after 2, 5, 8 and 10 minutes. For IMR
assessment with microcirculation disruption we selectively injected 40 mm
Embozene Microspheres (CeloNova BioSciences).
Results: A total of 112 IMR measurements were done. The coefﬁcient of variation
within the 3 transit time measurements in hyperaemia was 10 %. There were noJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrdifferences between the two doses of papaverine regarding Pd response and IMR
values, 11  4, 5 U with 5 mg de papaverine and 10, 6  3 U with 10 mg (p¼0.612).
Evolution in time of IMR was also similar with the two doses and differences with
resting values disappeared after 5 minutes (Figure). With microcirculation compro-
mised IMR increased to a mean value of 41  16 U (p¼0.001).Conclusions: IMR provides invasive and real time assessment of coronary micro-
circulation. A 5 mg dose of intracoronary papaverine is as effective as a 10 mg dose in
inducing maximal hyperemia. After 5 minutes of papaverine administration there is no
signiﬁcant differences to resting conditions.
TCT-809
Comparison of Symplicity Flex, Multi-Electrode Prototype and the Symplicity
Spyral Renal Denervation Catheters in a Porcine Model
Stefan Tunev1, Robert J. Melder1
1Medtronic Cardiovascular, Santa Rosa, CA
Background: Renal denervation (RDN) by radio frequency (RF) energy using the
Symplicity Flex catheter (Medtronic, Inc. Santa Rosa, CA) signiﬁcantly reduces blood
pressure in patients with resistant hypertension. Continued development of catheter
design resulted in a multi-electrode prototype and culminated in the Symplicity Spyral
catheter design, with an aim to maintain equivalent ablation performance. This study
compares the function of the Symplicity Flex, the Multi-Electrode prototype (ME) and
the Symplicity Spyral Denervation Catheters deployed in porcine model with regard to
RF-induced changes in tissue and degree of renal nerve ablation in porcine renal
arteries.
Methods: The vascular and nerve responses following RDN by RF energy was
evaluated quantitatively in normal swine at 28 days post-treatment by histology and
by renal norepinephrine quantiﬁcation. Naïve animals were used as control.
Results: Histologically, all treated renal arteries showed RF-induced lesions. Sym-
plicity Flex showed an average circumferential extension of the RF lesion in the
arterial media of 23% and 2220 microns in depth. Corresponding values for ME and
Symplicity Spyral arms were 22% and 25% extension and depth of RF changes as
2104 and 2357 microns respectively; there were no statistically signiﬁcant differences
between the three treatment arms. Endothelialization was >95% for all sections in all
arms. All three arms showed consistent average renal nerve ablation: nerve damage
was present in 59% of the sections for each vessel in the Symplicity Flex group and in
63% and 65% of the sections of the ME and Symplicity Spyral arms respectively. All
three treated arms showed a signiﬁcant drop in tissue norepinephrine as compared to
the control naïve animals. Immunohistochemistry showed that Symplicity Flex, ME
and Symplicity Spyral treatment signiﬁcantly decreased both functional renal artery
sympathetic nerves and cortical terminal axons as compared to the naïve animals
without statistical differences between treatments.
Conclusions: The Symplicity Flex, ME Prototype and Symplicity Spyral Renal
Denervation Catheters produced equivalent and consistent RF lesions, denervation
efﬁcacy and vascular safety.
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Background: An everolimus-eluting bioresorbable vascular scaffold (BVS, Abbott
Vascular, Santa Clara, CA) has shown promising clinical results; however, only
limited preclinical data has been published. We present detailed pathologic responses
to BVS versus XIENCE V (XV) in a porcine coronary model extending form 1
month (mo.) to 42 mo.
Methods: A total of 332 devices (261 BVS and 71 XV) were implanted in 2 or 3 main
coronary arteries of 135 non-atherosclerotic swine. The animals were euthanized andacts/POSTER/Basic Science, Animal Models, and Cell Therapy B245







Sexamined at 1 (n¼19 devices), 3 (n¼21), 6 (n¼21), 12 (n¼21), 18 (n¼19), 24
(n¼19), 30 (n¼20), 36 (n¼20), and 42 mo. (n¼21) by light microscopy or scanning
electron microscopy (SEM) (110 BVS and 71 XV). In addition, pharmacokinetics and
gel permeation chromatography (GPC) analysis were performed at various time
points.
Results: Vascular responses to BVS and XV were largely comparable at all time
points, with struts being sequestered in neointima. SEM conﬁrmed rapid endothelial
coverage by 1 mo. in both BVS and XV implanted arteries. Inﬂammation was
minimal to mild for both devices, though from 12 to 36 mo. mean scores were
greater for BVS. Pharmacokinetics revealed a similar drug release proﬁles for BVS
and XV. Consistent with drug elution, ﬁbrin deposition was similar between BVS
and XV at 1 mo. and rapidly decreased or was absent beyond 3 mo. Histo-
morphometry showed positive remodeling in BVS-implanted arteries that started
beyond 12 mo. Similarly, histomorphologic changes of BVS dismantling were
observed beyond 12 mo., and by 36 mo., resorption sites (pre-existing struts) of BVS
were poorly discernible from the surrounding neointima. GPC analysis conﬁrmed
that degradation of BVS could be considered complete by 36 mo. Additional
histochemical staining demonstrated inﬁltration of proteoglycans and collagen
between acellular homogenous hyaline material in resorption sites of BVS beginning
beyond 12 mo. with resorption sites being near completely composed of connective
tissue by 42 mo.
Conclusions: BVS demonstrates comparable safety to XV in porcine coronary arteries
with positive remodeling,minimal inﬂammation, and near complete degradation at 36mo.TCT-811
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Background: Intracoronary infusion of stem cells has typically been administered
through a standard single lumen, over-the-wire (OTW) 0.014" balloon catheter. These
catheters are not optimized for stem cell delivery, can compromise stem cell viability
and potential clinical efﬁcacy.
Methods: A Mesenchymal Stem Cell (MSC) solution with cell concentration of
2.5x106/ml was infused through a standard single lumen over-the-wire (OTW) 0.14"
balloon catheter during balloon inﬂation at 6, 8, 10 and 12 atmospheres (atms) at
a ﬂow rate of 1ml/min and during balloon inﬂation at 8 and 12 atms at ﬂow rate of
4ml/min. MSC samples were tested using trypan blue for viability before and after
passing through the standard balloon catheter wire lumen.
Results: Physical measurement of the inner lumen demonstrated collapsing of the
wire lumen during balloon inﬂation. Infusing through the catheter at a ﬂow rate of
1ml/minute, cell viability decreased from (97.5% to 91.7%), (95.7% to 94.1%),
(94.9% to 86.0%), (97.9% to 76.7%) at 6, 8, 10, and 12 atms respectively. When ﬂow
was increased to 4ml/minute, the cell survival decreased from (92.3% to 62.0%) and
from (91.3% to 60.8%) at 8 and 12 atms respectively.
Conclusions: A standard single lumen, over-the-wire (OTW) 0.014" angioplasty
balloon catheter can decrease stem cell viability and potentially affect the clinical
outcome of stem cell therapy.TCT-812
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Background: There is little available data regarding the long term follow-up of
patients treated with drug-eluting stent (DES) for Unprotected Left Main (ULM)
according to chronic kidney disease determined by estimated GFR (e-GFR).
Methods: All 1032 consecutive patients treated with DES implantation (ﬁrst and
second generation) for ULM stenosis between April 2005 and August 2011 were
retrospectively assessed for impact of renal function. Patients were classiﬁed into
normal renal function (60<; 567 patients), mild (30<60; 367 patients), moderateB246 JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j(15<30; 41 patients) and severe (<15; 57 patients) renal function groups. The
end-point of the study was a composite of major adverse cardiovascular events
(MACE) deﬁned as all cause death, myocardial infarction (MI) and TLR. Further-
more, the individual components of MACE, cardiac death, deﬁnite/probable stent
thrombosis (ST), possible ST and TLR for main-branch (TLR-MB) were evaluated.
Results: Patients with a lower e-GFR had more co-morbidities and complex lesions.
MACE, all cause death, cardiac death, TLR-MB, MI and deﬁnite/probable ST and
possible ST were more frequently observed when patients had more compromised
renal function (MACE at 5-years 33.1% in overall; 25.9% in normal, 35.0% in mild,
50.7% in moderate and 82.3% in severe, all cause death 17.0%; 10.1%, 18.0%,
42.8% and 68.1%,cardiac death 7.3%; 3.3%. 8.3%, 23.2% and 46.2%, TLR-MB
9.5%; 7.2%, 9.7%, 10.8% and 34.8% and MI 3.4%; 1.3%, 3.7%, 12.6% and 26.1%,
deﬁnite/probable ST 1.9%; 0.8%, 1.7%, 7.6% and 10.7%, and possible ST 5.2%;
1.9%, 5.7%, 14.6% and 38.5%, respectively). An estimated GFR was strongly
associated with all death (adjusted HR 0.979; 95%CI 0.972-0.987, p<0.001),
cardiac-death (adjusted HR 0.966; 95%CI 0.941-0.979, p<0.001), deﬁnite/probable
ST (HR 0.973; 95%CI 0.951-0.996, p¼0.024), possible ST (adjusted HR 0.964;
0.950-0.978, p<0.001) and TLR-MB (adjusted HR 0.987; 95%CI 0.977-0.997,
p¼0.009).
Conclusions: PCI in patients with ULM disease, the severity of CKD as determined
by estimated GFR, was associated with an increased risk of clinical events. Some of
adverse events may be related to progression of CKD.TCT-813
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Background: Although many biodegradable polymer based technologies are widely
used and tested in the clinical settings, still there is lack of data showing degradation
kinetics of a polymer in-vivo. The aim of this preclinical analysis was an evaluation of
sirolimus kinetics and biodegradable polymer (BP, poly-lactic acid) absorption from
the surface of drug eluting stent using a novel nuclear magnetic resonance (NMR)
method.
Methods: In 18 domestic swine 18 BP only coated stents (BPS) and 36 biodegradable
polymer sirolimus eluting stents (BP-SES) where implanted with 110% overstretch.
The animals were sacriﬁced at 1, 3, 7, 14, 28 and 56 days follow-up (9 segments per
time point). Vessel segments with BPS were harvested to evaluate polymer degra-
dation with a novel NMR method, whereas BP-SES to test sirolimus tissue uptake and
retention. In the NMR method a cryoplatform and cryoprobe were used to optimize
observation of resonance signals in H-1 NMR spectrum. The lactide molecules as an
internal standard were used to conﬁrm quantity of polymers on stent surface. Siroli-
mus pharmacokinetic analysis was performed with the use of standard liquid chro-
matography (HPLC) method in order to check its correlation with BP absorption as the
polymer degradation and drug release should run almost in parallel during the ﬁrst
four weeks after stent implantation.
Results: The NMR method showed a gradual absorption of the polymer over the
six consecutive time points, from 5.48 mg of the polymer on the stent at 1 day
follow-up, through 4.33 mg at 3 days, 3.16 mg at 7 days, 2.42 mg at 14 days, 1.92
mg at 28 days to 1.24 mg in the last day of the study. In addition this method
showed a good correlation with widely used and standardized HPLC method for
sirolimus elution.
Conclusions: The novel NMR method for BP absorption kinetics evaluation is
a useful tool which may be widely adopted to test other biodegradable applications.
Further, it may substantially improve their safety and efﬁcacy by facilitating pro-
grammed polymer and drugs elution. The polymer degradation pattern will be
essential in designing a study with the aim to shorten double antiplatelet therapy.TCT-814
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Background: X-Ray with its known disadvantages of iodinated contrast agents,
ionizing radiation and lack of soft tissue contrast is currently used for percutaneous
closure of PFOs, ASDs and VSDs. Cardiac MRI imaging is compromised by the
artifacts of commercial occluders that have been tested. The new MR-Enhancing
occluder functions as a local ampliﬁer of the MRI signal and improves imaging and
MRI guided closure.
Methods: Resonant occluder manufactured from a Nitinol tube (Ø ¼ 0.2 mm) is
designed so that it includes inductivity and capacity necessary for a resonant circuit.TCT Abstracts/POSTER/Basic Science, Animal Models, and Cell Therapy
